Affiliations: [a] North East London NHS Foundation Trust, London, UK
| [b] Croydon Health Services NHS Trust, London, UK
| [c] Division of Psychiatry, University College London, London, UK
| [d] Research Department of Clinical, Educational and Health Psychology, University College London, London, UK
Correspondence:
[*]
Correspondence to: Ciarán O’Driscoll, E-mail: ucjtcio@ucl.ac.uk.
Abstract: The Montreal Cognitive Assessment (MoCA) is widely used to screen for mild cognitive impairment (MCI). While there are many available versions, the cross-cultural validity of the assessment has not been explored sufficiently. We aimed to interrogate the validity of the MoCA in a cross-cultural context: in differentiating MCI from normal controls (NC); and identifying cut-offs and adjustments for age and education where possible. This review sourced a wide range of studies including case-control studies. In addition, we report findings for differentiating dementias from NC and MCI from dementias, however, these were not considered to be an appropriate use of the MoCA. The subject of the review assumes heterogeneity and therefore meta-analyses was not conducted. Quality ratings, forest plots of validated studies (sensitivity and specificity) with covariates (suggested cut-offs, age, education and country), and summary receiver operating characteristic curve are presented. The results showed a wide range in suggested cutoffs for MCI cross-culturally, with variability in levels of sensitivity and specificity ranging from low to high. Poor methodological rigor appears to have affected reported accuracy and validity of the MoCA. The review highlights the necessity for cross-cultural considerations when using the MoCA, and recognizing it as a screen and not a diagnostic tool. Appropriate cutoffs and point adjustments for education are suggested.
Keywords: Cross-cultural, dementia, mild cognitive impairment, Montreal Cognitive Assessment
